Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Palantir Technologies is highly profitable but currently overvalued, with EV/EBITDA ratio of 676.74 and P/E ratio of 513.78.

Palantir shares closed at a record high Wednesday for the second consecutive day, as a cooling of global trade tensions has ...

The Dow Jones Industrial Average fell in early trades in the stock market today. Nvidia gained along with several tech leaders.

Key Points Tarrifs, President Trump’s visit to Saudi Arabia and global uncertainty has had a huge impact on tech stocks this ...

Palantir stock hit a new all-time high on Wednesday as the tech-heavy Nasdaq composite also gained. Palantir stock traded in a buy zone amid a 71% advance in 2025.

Palantir (PLTR) opened comfortably in the green on Wednesday following news that Heather Planishek, its former chief ...

Tech sector volatility remains high due to tariffs and supply chain uncertainty; recent relief rallies may be temporary as ...

Live Updates Live Coverage Updates appear automatically as they are published. Winners & Losers 11:05 am by Super Micro ...

Live Updates Live Coverage Updates appear automatically as they are published. Bullish on Tech 10:21 am by Gerelyn Terzo Bank of America is adopting a more optimistic stance on major technology ...

Live Updates Live Coverage Updates appear automatically as they are published. Saudi Tech Deals 9:55 am by Gerelyn Terzo Bank ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...